Drug maker tests new paxlovid pill formula
NCT ID NCT06397144
First seen Jan 08, 2026 · Last updated Apr 22, 2026 · Updated 14 times
Summary
This study aimed to see if a new, combined tablet form of the COVID-19 medication Paxlovid works the same way in the body as the original separate pills. It planned to test this in about 28 healthy adult volunteers by giving them single doses of the different forms and measuring drug levels in their blood. The study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.